病毒性肝炎健康管理专家共识(2021年)

2021-08-30 中华医学会健康管理学分会 中华健康管理学杂志

乙型与丙型病毒性肝炎是肝硬化、肝细胞癌的重要病因之一。我国约有7 000万例慢性乙型肝炎病毒(HBV)感染者和1 000万例慢性丙型肝炎病毒(HCV)感染者。

中文标题:

病毒性肝炎健康管理专家共识(2021年)

发布日期:

2021-08-30

简要介绍:

乙型与丙型病毒性肝炎是肝硬化、肝细胞癌的重要病因之一。我国约有7 000万例慢性乙型肝炎病毒(HBV)感染者和1 000万例慢性丙型肝炎病毒(HCV)感染者。世界卫生组织提出到2030年消除病毒性肝炎作为公共卫生危害的目标,而健康体检是目前我国发现HBV与HCV感染者和患者的主要途径之一。为此,中华医学会健康管理学分会、中华医学会肝病学分会、中华医学会检验医学分会组织相关专家制定本共识,希望提高健康管理部门对体检人群关于病毒性肝炎咨询和转诊的规范性,促进健康管理机构与临床、检验的多学科、多部门联合,从而推广在健康体检中病毒性肝炎的筛查,有助于促进病毒性肝炎患者的诊断和抗病毒治疗。

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212157, encodeId=cff3121215e56, content=收藏学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 18 12:08:07 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085490, encodeId=1239108549073, content=消除病毒性肝炎,恐怕是个漫长的过程, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c705541013, createdName=ms2000001734502670, createdTime=Wed Dec 29 16:22:23 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081720, encodeId=4f001081e20b3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83365415480, createdName=ms1000000764841546, createdTime=Sun Dec 19 09:07:57 CST 2021, time=2021-12-19, status=1, ipAttribution=)]
    2022-04-18 ms3000000771933475

    收藏学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212157, encodeId=cff3121215e56, content=收藏学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 18 12:08:07 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085490, encodeId=1239108549073, content=消除病毒性肝炎,恐怕是个漫长的过程, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c705541013, createdName=ms2000001734502670, createdTime=Wed Dec 29 16:22:23 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081720, encodeId=4f001081e20b3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83365415480, createdName=ms1000000764841546, createdTime=Sun Dec 19 09:07:57 CST 2021, time=2021-12-19, status=1, ipAttribution=)]
    2021-12-29 ms2000001734502670

    消除病毒性肝炎,恐怕是个漫长的过程

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212157, encodeId=cff3121215e56, content=收藏学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 18 12:08:07 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085490, encodeId=1239108549073, content=消除病毒性肝炎,恐怕是个漫长的过程, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c705541013, createdName=ms2000001734502670, createdTime=Wed Dec 29 16:22:23 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081720, encodeId=4f001081e20b3, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83365415480, createdName=ms1000000764841546, createdTime=Sun Dec 19 09:07:57 CST 2021, time=2021-12-19, status=1, ipAttribution=)]
    2021-12-19 ms1000000764841546

    很有帮助

    0

拓展阅读

2016 ECIL-5建议:血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2016-05-01

2019 AST指南:病毒性肝炎

美国移植学会(AST,American Society of Transplantation) · 2019-02-28

2019 BC指南:病毒性肝炎的检测(草案)

不列颠哥伦比亚省临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2019-05-20

2020 KASID临床实践指南:炎症性肠病患者病毒性肝炎的预防和管理

国外消化科相关专家小组(统称) · 2020-01-28

慢性丙型病毒性肝炎直接抗病毒药物临床试验技术指导原则(征求意见稿)

国家药品监督管理局药品审评中心(CDE) · 2021-09-16

2021 BC指南:病毒性肝炎的检测

不列颠哥伦比亚省临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2021-05-26